Back to Search
Start Over
Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).
- Source :
-
Emerging microbes & infections [Emerg Microbes Infect] 2015 Jun 17; Vol. 4, pp. e37. Date of Electronic Publication: 2015 Jun 17. - Publication Year :
- 2015
- Subjects :
- Antibodies, Monoclonal therapeutic use
Antiviral Agents therapeutic use
Communicable Diseases, Emerging prevention & control
Coronavirus Infections prevention & control
Drug Synergism
Humans
Middle East Respiratory Syndrome Coronavirus genetics
Middle East Respiratory Syndrome Coronavirus immunology
Protein Domains
Viral Fusion Protein Inhibitors pharmacology
Antibodies, Monoclonal pharmacology
Antiviral Agents pharmacology
Communicable Diseases, Emerging drug therapy
Coronavirus Infections drug therapy
Middle East Respiratory Syndrome Coronavirus drug effects
Spike Glycoprotein, Coronavirus antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 2222-1751
- Volume :
- 4
- Database :
- MEDLINE
- Journal :
- Emerging microbes & infections
- Publication Type :
- Editorial & Opinion
- Accession number :
- 26954884
- Full Text :
- https://doi.org/10.1038/emi.2015.37